603 Live Notices for Germany Uniforms Tenders
Showing 1 to 20
Expansion Of The Employer Branding Area On The Baua Website
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So-Called Open House Procedure.
Update Of Hwgk - Framework Agreement Dl2 Hydraulic Quality Assurance And Technical Consulting
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So-Called Open House Procedure.
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So-Called Open House Procedure.
Open House Original Discount Agreements 2024-16 - Formoterol_Glycopyrronium_Budesonide (Active Ingredient Combination)
Ecl@Zeno: Hfk-Ba 1 - Shreinearbeiten Ii
Further Education And Training In The Context Of The Digitalization Of The Public Health Service (Ögd) And The Introduction Of The Specialist Application Ögdigital
Update Of Hwgk - Framework Agreement Dl3 Hydrology: Quality Assurance And Technical Advice
Tender For A Patient Portal
Dstw Mainz Planning Superstructure
Polbln 501_24 Rv Leg Protection And Groin Protection
Open House Original Discount Agreements 2024-12 - Tofacitinib
Open House Original Discount Contracts 2024-14 - Bimatoprost / Timolol (Dosage Form: Eye Drops As Single-Dose Pipettes)
Open House Biologics Discount Agreements 2024-12 - Dornase Alfa
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So-Called Open House Procedure.
Update Hwgk - Framework Agreement Dl1 Data: Quality Assurance And Specialist Advice
Dstw Mainz Planning Superstructure
Open House Original Discount Agreements 2024-12 - Tofacitinib
Update Hwgk - Framework Agreement Dl1 Data: Quality Assurance And Specialist Advice